In conclusion, our research indicates that SOCS3 was valuable for diagnosis, staging, histological subtyping, prognosis, and therapeutic response of several types of cancer in the context of immuno-oncology through different mechanisms, and those genetic or epigenetic alterations in the SOCS3 genes were often predictive of a poor prognosis. Here, SOCS3 is linked to cancer.